As of 2025-11-06, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (89.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.07 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -489.4%.
The range of the Relative Valuation is (75.26) - (94.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 23.9x | 20.6x |
| Forward P/E multiples | 19.1x - 30.8x | 25.0x |
| Fair Price | (75.26) - (94.01) | (89.83) |
| Upside | -426.2% - -507.5% | -489.4% |
| Date | P/E |
| 2025-11-05 | -5.86 |
| 2025-11-04 | -5.77 |
| 2025-11-03 | -6.15 |
| 2025-10-31 | -6.35 |
| 2025-10-30 | -6.04 |
| 2025-10-29 | -6.29 |
| 2025-10-28 | -6.71 |
| 2025-10-27 | -6.78 |
| 2025-10-24 | -7.10 |
| 2025-10-23 | -7.16 |
| 2025-10-22 | -7.03 |
| 2025-10-21 | -7.59 |
| 2025-10-20 | -7.77 |
| 2025-10-17 | -6.59 |
| 2025-10-16 | -6.55 |
| 2025-10-15 | -6.90 |
| 2025-10-14 | -6.45 |
| 2025-10-13 | -6.44 |
| 2025-10-10 | -6.68 |
| 2025-10-09 | -7.07 |
| 2025-10-08 | -6.85 |
| 2025-10-07 | -6.38 |
| 2025-10-06 | -6.57 |
| 2025-10-03 | -6.54 |
| 2025-10-02 | -6.49 |
| 2025-10-01 | -6.12 |
| 2025-09-30 | -6.16 |
| 2025-09-29 | -6.07 |
| 2025-09-26 | -5.83 |
| 2025-09-25 | -5.86 |
| 2025-09-24 | -5.99 |
| 2025-09-23 | -6.02 |
| 2025-09-22 | -6.20 |
| 2025-09-19 | -6.17 |
| 2025-09-18 | -6.37 |
| 2025-09-17 | -5.70 |
| 2025-09-16 | -5.81 |
| 2025-09-15 | -5.40 |
| 2025-09-12 | -5.23 |
| 2025-09-11 | -5.47 |
| 2025-09-10 | -5.05 |
| 2025-09-09 | -5.17 |
| 2025-09-08 | -5.06 |
| 2025-09-05 | -5.30 |
| 2025-09-04 | -4.71 |
| 2025-09-03 | -4.76 |
| 2025-09-02 | -4.14 |
| 2025-08-29 | -4.15 |
| 2025-08-28 | -4.28 |
| 2025-08-27 | -4.28 |